Share this article

print logo

Letter: Congress should take action on the high cost of all drugs

Congress should take action on the high cost of all drugs

Well, it is good to see that Congress is getting involved with the outrageous price increase of EpiPen.

Perhaps now would be a good time to make this a standing committee of Congress in order to investigate other similar instances of price gouging by Big Pharma.

About 11 years ago my wife was diagnosed with multiple sclerosis. The drug that was prescribed was an injectable that she had to administer every day. At that time the drug cost $1,200 per month, which at that time was among the most expensive of its type.

She asked why it was so expensive and was told it was because of the very expensive research and development costs.

Today that same drug costs just about $6,000. So now what justifies this exorbitant price increase?

Many patients who take this drug are now finding that manageable copays are skyrocketing from $50 per month to as much as $500 per month.

They, along with those with no insurance coverage, are being confronted with making decisions about food or drugs.

This is but one example. There are many other multiple sclerosis drugs that are similarly priced as well as many other drugs that are used to treat a wide range of diseases.

It is interesting to note that in Canada this same drug can be purchase for from $1,400 to $1,600 per month. What are they doing right that our country can emulate? Does anyone even care?

Ed Drozen

East Amherst

There are no comments - be the first to comment